Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
As of Nov 14, 2026, ANDA 74201 (Naproxen), held by Teva, was first approved by FDA on Dec 21, 1993, with 19 approved supplements and 0 published complete response letters.
First approved: Dec 21, 1993
Supplements approved: 19
Complete response letters: 0
Approvals and New Uses
The original application and every efficacy supplement, newest first; all 20 submissions below
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
